Dinesh Khanna

Dinesh Khanna

UNVERIFIED PROFILE

Are you Dinesh Khanna?   Register this Author

Register author
Dinesh Khanna

Dinesh Khanna

Publications by authors named "Dinesh Khanna"

Are you Dinesh Khanna?   Register this Author

100Publications

2659Reads

26Profile Views

Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument.

Arthritis Res Ther 2020 Jan 6;22(1). Epub 2020 Jan 6.

Department of Internal Medicine, University of Michigan Scleroderma Program, Suite 7C27, 300 North Ingalls Street, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-2087-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945532PMC
January 2020

Aetiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.

Am J Respir Crit Care Med 2019 Dec 16. Epub 2019 Dec 16.

Feinberg School of Medicine, Northwestern Scleroderma Program, Chicago, Illinois, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201903-0563CIDOI Listing
December 2019

Fatigue and its Association with Social Participation, Functioning and Quality of Life in Systemic Sclerosis.

Arthritis Care Res (Hoboken) 2019 Dec 16. Epub 2019 Dec 16.

University of Michigan, Division of Rheumatology, 300 North Ingalls Street, SPC 5422, Suite 7C27, Ann Arbor, Michigan, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.24122DOI Listing
December 2019

Response to: 'Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series' by Narváez.

Ann Rheum Dis 2019 Nov 23;78(11):e124. Epub 2018 Oct 23.

Product Development, Genentech, Inc, South San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214477DOI Listing
November 2019

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.

J Rheumatol 2019 Oct 15;46(10):1316-1325. Epub 2019 Feb 15.

From the Department of Medicine and Department of Radiology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California; Department of Biomathematics, University of California, Los Angeles, California; Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697251PMC
October 2019

Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease.

Clin Exp Rheumatol 2019 Jul-Aug;37 Suppl 119(4):49-56. Epub 2019 Sep 4.

University of Michigan Scleroderma Program, Division of Rheumatology Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
October 2019

Drug initiation and escalation strategies of vasodilator therapies for Raynaud's phenomenon: can we treat to target?

Rheumatology (Oxford) 2019 Oct 31. Epub 2019 Oct 31.

Royal National Hospital for Rheumatic Diseases, Royal United Hospitals.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez522DOI Listing
October 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Ann Rheum Dis 2019 Sep 5;78(9):1151-1159. Epub 2019 Aug 5.

Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île deFrance, Cochin Hospital, Université Paris Descartes-Sorbonne Paris Cité, INSERM U1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214819DOI Listing
September 2019

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Arthritis Rheumatol 2019 09 6;71(9):1400-1412. Epub 2019 Aug 6.

Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827566PMC
September 2019

A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers.

Arthritis Res Ther 2019 Sep 3;21(1):202. Epub 2019 Sep 3.

Division of Rheumatology/Department of Internal Medicine, University of Michigan Scleroderma Program, Suite 7C27, 300 North Ingalls Street, SPC 5422, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-019-1979-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724329PMC
September 2019

Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis.

Eur Respir J 2019 Aug 22;54(2). Epub 2019 Aug 22.

Division of Rheumatology and Scleroderma Program, Dept of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.00586
Publisher Site
http://dx.doi.org/10.1183/13993003.00586-2019DOI Listing
August 2019

Development and Pilot Testing of MyGoutCare: A Novel Web-Based Platform to Educate Patients With Gout.

J Clin Rheumatol 2019 Aug 12. Epub 2019 Aug 12.

From the Department of Medicine, Division of Rheumatology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000001126DOI Listing
August 2019

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

J Rheumatol 2019 Jul 15;46(7):721-726. Epub 2018 Dec 15.

From the Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, Mount Sinai Hospital, Toronto; University Health Network, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Department of Medicine, University of Michigan, Ann Arbor, Michigan; University of California, Los Angeles, Los Angeles; University of California, San Francisco, California; Brigham and Women's Hospital, Boston; Harvard Medical School, Boston, Massachusetts; Medical University of South Carolina, Charleston, South Carolina; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Hospital Clínic, Barcelona, Spain; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île de France, Paris; Université Paris Descartes-Sorbonne Paris Cité, Paris; INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin; Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin; University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; National and Kapodestrian University of Athens, and Biomedical Research Foundation of the Athens Academy, Athens, Greece; Department of Medicine, University of Cambridge, Cambridge, UK; University of Pisa, Pisa, Italy; Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180478DOI Listing
July 2019

Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

Semin Arthritis Rheum 2019 06 14;48(6):1059-1067. Epub 2018 Oct 14.

Division of Rheumatology, Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2018.10.010DOI Listing
June 2019

Management of systemic sclerosis-associated interstitial lung disease.

Curr Opin Rheumatol 2019 05;31(3):241-249

Department of Internal Medicine, Division of Rheumatology, Scleroderma Program.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0000000000000592DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647025PMC
May 2019

Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.

Semin Arthritis Rheum 2019 Feb 4;48(4):686-693. Epub 2018 Apr 4.

Department of Experimental and Clinical Medicine, University of Florence & Department of Geriatric Medicine, Division of Rheumatology AOUC, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2018.03.019DOI Listing
February 2019

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.

J Rheumatol 2019 02 1;46(2):176-183. Epub 2018 Oct 1.

From the Department of Medicine, Division of Rheumatology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey; Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Stanford, California; Department of Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Department of Medicine, Division of Rheumatology, Boston University, Boston; Department of Medicine, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Department of Medicine, Division of Rheumatology, and Pulmonary Sciences and Critical Care Medicine, University of Colorado, Denver, Colorado; Department of Medicine, Division of Rheumatology, Northwestern University, Chicago, Illinois; Department of Medicine, Division of Rheumatology, New York University Medical Center, New York, New York; Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Division of Rheumatology, Albany Medical College, Albany, New York; Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Medicine, Division of Rheumatology, University of Texas, Houston, Texas; Department of Medicine, Division of Rheumatology, University of California at Los Angeles, Los Angeles, California; Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Medicine, Division of Rheumatology, University of Minnesota, Minneapolis, Minnesota; Department of Medicine, Divisions of Pulmonary and Rheumatology, Tulane University, New Orleans, Louisiana; Department of Epidemiology and Health Promotion, New York University, New York, New York; Department of Medicine, Division of Rheumatology, Immunology and Allergy, Georgetown University, Washington, D.C., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180018DOI Listing
February 2019

Reply.

Arthritis Rheumatol 2019 02 29;71(2):327-328. Epub 2018 Dec 29.

Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.40762
Publisher Site
http://dx.doi.org/10.1002/art.40762DOI Listing
February 2019

Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma.

Proc Natl Acad Sci U S A 2019 02 12;116(9):3695-3702. Epub 2019 Feb 12.

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1813006116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397533PMC
February 2019

The patient experience of Raynaud's phenomenon in systemic sclerosis.

Rheumatology (Oxford) 2019 01;58(1):18-26

Division of Rheumatology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293480PMC
January 2019

Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.

Clin Exp Rheumatol 2018 Jul-Aug;36 Suppl 113(4):146-149. Epub 2018 Sep 30.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
January 2019

Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium.

J Rheumatol 2019 01 15;46(1):78-84. Epub 2018 Nov 15.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180004DOI Listing
January 2019

Diagnosis of pulmonary hypertension.

Eur Respir J 2019 Jan 24;53(1). Epub 2019 Jan 24.

Dept of Pulmonary Circulation and Cardidology, Medical Center for Postgraduate Education, ECZ-Otwock, Otwock, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01904-2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351333PMC
January 2019

Burden of Gastrointestinal Symptoms in the United States: Results of a Nationally Representative Survey of Over 71,000 Americans.

Am J Gastroenterol 2018 11 15;113(11):1701-1710. Epub 2018 Oct 15.

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Division of Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA. Division of Informatics, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Division of Gastroenterology, Michigan Medicine, Ann Arbor, MI, USA. Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Division of Rheumatology, Michigan Medicine, Ann Arbor, MI, USA. Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41395-018-0256-8
Publisher Site
http://dx.doi.org/10.1038/s41395-018-0256-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453579PMC
November 2018

Monoclonal Gammopathy-Associated Scleromyxedema Presenting as Leonine Facies.

Arthritis Rheumatol 2018 10;70(10):1694

University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160324PMC
October 2018

Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.

Ann Rheum Dis 2018 08 14;77(8):1208-1218. Epub 2018 May 14.

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-213022DOI Listing
August 2018

Establishing clinical severity for PROMIS measures in adult patients with rheumatic diseases.

Qual Life Res 2018 Mar 5;27(3):755-764. Epub 2017 Oct 5.

Division of Rheumatology, University of Michigan, 300 North Ingalls Building, Room 7C27, Ann Arbor, MI, 48109-5422, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-017-1709-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845827PMC
March 2018

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 01;378(1):35-47

From the Duke University Medical Center (K.M.S., O.C., E.W.S.C.) and RTI International (D.W.), Durham, and Rho Federal Systems Division, Chapel Hill (L.K.-E., A.P., B.E., S.C.) - all in North Carolina; National Institute of Allergy and Infectious Diseases, Bethesda, MD (E.A.G., B.W., L.M.G., J.S.G.); Colorado Blood Cancer Institute, Denver (P.A.M., R.A.N.); University of Texas McGovern Medical School (M.D.M.) and M.D. Anderson Cancer Center (C.H.) - both in Houston; Vanderbilt University, Nashville (L.J.C., K.P.); University of Michigan, Ann Arbor (D.K., J.R.S.); Case Western Reserve University and University Hospitals, Cleveland (R.J.F.); University of Alabama, Birmingham (S.M.); Boston University, Boston (R.W.S.); University of Virginia, Charlottesville (K.B.); University of Washington (M.H.W., D.E.F.) and the Fred Hutchinson Cancer Research Center (G.E.G., S.H.) - both in Seattle; University of California, Los Angeles, Los Angeles (J.G., S.K., D.E.F.); City of Hope National Medical Center, Duarte, CA (S.F.); Medical University of South Carolina, Charleston (R.M.S.); Mayo Clinic, Scottsdale, AZ (L.G.); University of Calgary, Calgary, AB, Canada (J.S., S.L.); Washington University, St. Louis (R.B.); Medical College of Wisconsin, Milwaukee (M.E.C., C.K.-T.); Ottawa Hospital Research Institute, Ottawa (C.B.); University of Pittsburgh, Pittsburgh (T.M., R.T.D.); and University of Toledo Medical Center, Toledo, OH (M.B.K.).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846574PMC
http://dx.doi.org/10.1056/nejmoa1703327DOI Listing
January 2018

Systemic sclerosis.

Lancet 2017 Oct 13;390(10103):1685-1699. Epub 2017 Apr 13.

University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(17)30933-9DOI Listing
October 2017

Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.

Rheumatology (Oxford) 2017 09;56(suppl_5):v23-v26

Michigan Scleroderma Program, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850357PMC
September 2017

Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v4-v11

Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850471PMC
September 2017

Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Rheumatology (Oxford) 2017 09;56(suppl_5):v38-v44

Department of Rheumatology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850276PMC
September 2017

Points to consider when doing a trial primarily involving the heart.

Rheumatology (Oxford) 2017 09;56(suppl_5):v12-v16

Department of Cardiology, Cochin Hospital, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850499PMC
September 2017

Points to consider-Raynaud's phenomenon in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v45-v48

The University of Manchester, Salford Royal NHS Foundation Trust, Manchester and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850109PMC
September 2017

Points to consider for skin ulcers in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v67-v71

Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, AOU Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850787PMC
September 2017

Points to consider in renal involvement in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v49-v52

Department of Clinical and Experimental Medicine, Division of Rheumatology, University of Florence, AOU Careggi, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850113PMC
September 2017

Assessment of skin involvement in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v53-v66

Department of Rheumatology and Immunology, Medical School, University of Pécs, Pécs.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850338PMC
September 2017

Interstitial lung disease points to consider for clinical trials in systemic sclerosis.

Rheumatology (Oxford) 2017 09;56(suppl_5):v27-v32

Department of Medicine, Royal Brompton Hospital, Faculty of Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850349PMC
September 2017

Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort.

J Rheumatol 2017 06 15;44(6):791-794. Epub 2017 Mar 15.

From the Department of Rheumatology, and Department of Epidemiology and Biostatistics, Hospital for Special Surgery; Department of Rheumatology, Columbia University, New York, New York; Department of Radiology, and Department of Biostatistics, University of Michigan; University of Michigan Scleroderma Program, Ann Arbor, Michigan; Department of Rheumatology, University of Texas, Houston, Texas; Department of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Department of Rheumatology, Northwestern University, Chicago, Illinois; Department of Rheumatology, Georgetown University, Washington, DC; Department of Rheumatology, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457319PMC
June 2017

Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.

J Rheumatol 2017 06 15;44(6):795-798. Epub 2017 Apr 15.

From the San Diego State University (SDSU)/University of California (UC) San Diego Joint Doctoral Program in Clinical Psychology, Department of Psychology, San Diego; Department of Psychology, California State University, Dominguez Hills; SDSU, Department of Psychology, San Diego; David Geffen School of Medicine, University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, California; University of Michigan Health System, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457305PMC
June 2017

Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales.

Dig Dis Sci 2017 05 1;62(5):1186-1192. Epub 2017 Mar 1.

Division of General Internal Medicine & Health Services Research, David Geffen School of Medicine at UCLA, 911 Broxton Avenue, Los Angeles, CA, 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-017-4499-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532518PMC
May 2017

Gastrointestinal Manifestations of Systemic Sclerosis.

J Scleroderma Relat Disord 2016 18;1(3):247-256. Epub 2016 Oct 18.

Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/jsrd.5000214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267349PMC
October 2016

Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Curr Treatm Opt Rheumatol 2016 Sep 19;2(3):252-269. Epub 2016 Jul 19.

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; University of Michigan Scleroderma Program, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40674-016-0052-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176259PMC
September 2016